Ftse Mib
32.963,53
-0,62%
DAX
19.252,79
-0,27%
S&P 500
6.021,63
0,57%
NASDAQ
19.175,58
0,63%
Bitcoin
93.214,68
1,35%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Vincerx Inc (VINC) Vincerx Inc (VINC) Notizie

VINC

Vincerx (VINC)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:VINC
DataOraFonteTitoloSimboloCompagnia
25/11/202423:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VINCVincerx Inc
12/11/202415:00GlobeNewswire Inc.Vincerx Pharma Reports Third Quarter 2024 Financial ResultsNASDAQ:VINCVincerx Inc
05/11/202415:15Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:VINCVincerx Inc
07/10/202422:05GlobeNewswire Inc.Vincerx Reports Positive Initial Clinical Data from Ongoing VIP943 Phase 1 Dose-Escalation Study and Provides Pipeline and Corporate UpdatesNASDAQ:VINCVincerx Inc
30/09/202412:57Edgar (US Regulatory)Form SC TO-I/A - Tender offer statement by Issuer: [Amend]NASDAQ:VINCVincerx Inc
15/08/202402:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VINCVincerx Inc
13/08/202422:06Edgar (US Regulatory)Form SC TO-I - Tender offer statement by IssuerNASDAQ:VINCVincerx Inc
08/08/202422:39Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VINCVincerx Inc
08/08/202422:30GlobeNewswire Inc.Vincerx Pharma Reports Second Quarter 2024 Financial ResultsNASDAQ:VINCVincerx Inc
02/08/202422:01Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:VINCVincerx Inc
08/07/202422:45Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:VINCVincerx Inc
14/05/202422:15GlobeNewswire Inc.Vincerx Pharma Reports First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:VINCVincerx Inc
26/04/202406:27GlobeNewswire Inc.Vincerx Pharma Announces Pricing of Underwritten Public Offering of Common Stock and WarrantsNASDAQ:VINCVincerx Inc
25/04/202422:01GlobeNewswire Inc.Vincerx Pharma Announces Proposed Underwritten Public Offering of Common Stock and WarrantsNASDAQ:VINCVincerx Inc
08/04/202422:30GlobeNewswire Inc.Vincerx Pharma Presents Positive Preliminary Phase 1 Data for VIP236 and Updates on Pipeline Progress at the American Association for Cancer Research (AACR) Annual Meeting 2024 NASDAQ:VINCVincerx Inc
01/04/202414:00GlobeNewswire Inc.Vincerx to Host Virtual Investor Event Reviewing Preliminary Phase 1 VIP236 Data Presented at the American Association for Cancer Research (AACR) Annual Meeting 2024NASDAQ:VINCVincerx Inc
29/03/202420:20GlobeNewswire Inc.Vincerx Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate UpdateNASDAQ:VINCVincerx Inc
05/03/202422:31GlobeNewswire Inc.Vincerx to Present Three Posters at the American Association for Cancer Research (AACR) Annual Meeting 2024NASDAQ:VINCVincerx Inc
13/10/202315:12GlobeNewswire Inc.New to The Street Airs Televised Corporate Interviews Episodes 521 and 522 as Sponsored Programming on Bloomberg TV and The Fox Business NetworkNASDAQ:VINCVincerx Inc
06/10/202315:30GlobeNewswire Inc.New to The Street Announces TV Corporate Appearances, broadcasting Episode 518 on Newsmax and Episode 519 on FOX Business Network, Airings start on Saturday, October 7, 2023, at 3:30 PM ETNASDAQ:VINCVincerx Inc
20/06/202322:07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VINCVincerx Inc
11/05/202322:02Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:VINCVincerx Inc
12/04/202322:14Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:VINCVincerx Inc
28/03/202323:07Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:VINCVincerx Inc
28/03/202322:50Edgar (US Regulatory)Annual Report (10-k)NASDAQ:VINCVincerx Inc
16/02/202322:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VINCVincerx Inc
10/02/202322:02Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:VINCVincerx Inc
14/11/202204:55TipRanksSVB Securities Sticks to Its Buy Rating for Vincerx Pharma Inc (VINC)NASDAQ:VINCVincerx Inc
07/11/202204:35TipRanksSVB Securities Remains a Buy on Vincerx Pharma Inc (VINC)NASDAQ:VINCVincerx Inc
12/08/202214:36TipRanksVincerx Pharma Inc (VINC) Receives a Buy from SVB SecuritiesNASDAQ:VINCVincerx Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:VINC

La tua Cronologia

TG
LYQ7
Lyxor Asset Management L...
NASDAQ
UROY
Uranium Royalty
AMEX
LFEQ
VanEck Long Flat Trend ETF
BIT
PAEM
Exchange Traded Fund Ivz...
BIT
P12V96
BNP PARIBAS ISSUANCE
BOV
BIYT39R
BlackRock Institutional ...
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network